ClinicalTrials.govpublic full text
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
metastatic colorectal cancer, sotorasib, panitumumab, folfiri, bevacizumab-awwb, oncology, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 828989
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.